Showing results (1651-1660 of 1,763) with videos related to

Sort By:
Pageof 177
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 25, 2005
Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer painJoseph R Ghilardi, Heidi Röhrich, Theodore H Lindsay, et al.
Plos Computational Biology|November 2, 2020
Quantification of Ebola virus replication kinetics in vitroLaura E Liao, Jonathan Carruthers, Sophie J Smither, et al.
Current Problems in Cancer|August 23, 2020
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancerThiru Prasanna, Rachel Wong, Timothy Price, et al.
Journal of Medicinal Chemistry|June 19, 2015
Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical CandidateMichael A Letavic, Pascal Bonaventure, Nicholas I Carruthers, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Lead Optimization of 5-Aryl Benzimidazolone- and Oxindole-Based AMPA Receptor Modulators Selective for TARP γ-8Suchitra Ravula, Brad M Savall, Nyantsz Wu, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2010
Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonistsEmily M Stocking, Leah Aluisio, John R Atack, et al.
Journal of Biomedical Materials Research. Part A|July 23, 2013
Polypropylene surgical mesh coated with extracellular matrix mitigates the host foreign body responseMatthew T Wolf, Christopher A Carruthers, Christopher L Dearth, et al.
BMC Genomics|August 5, 2015
High-throughput and quantitative genome-wide messenger RNA sequencing for molecular phenotypingJohn E Collins, Neha Wali, Ian M Sealy, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosisJackie T Yik, Pierre Becquart, Jasmine Gill, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2012
Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorderPascal Bonaventure, Christine Dugovic, Michelle Kramer, et al.
Pageof 177